Glen Harbor Capital Management’s AbbVie ABBV Stock Holding History

Glen Harbor Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$13M	Buy	171,972 +63,172	+58%	+$4.33M	0.27%	76
2019 Q2	$7.91M	Sell	108,800 -4,352	-4%	-$342K	0.17%	131
2019 Q1	$9.12M	Sell	113,152 -92,956	-45%	-$7.6M	0.2%	112
2018 Q4	$19M	Sell	206,108 -74,936	-27%	-$6.59M	0.46%	48
2018 Q3	$26.6M	Buy	281,044 +54,944	+24%	+$5.21M	0.53%	44
2018 Q2	$20.9M	Buy	226,100 +16,014	+8%	+$1.56M	0.45%	53
2018 Q1	$19.9M	Buy	210,086 +105,196	+100%	+$11.6M	0.45%	55
2017 Q4	$10.1M	Buy	104,890 +79,730	+317%	+$7.51M	0.23%	94
2017 Q3	$2.24M	Sell	25,160 -3,842	-13%	-$292K	0.05%	279
2017 Q2	$2.1M	Sell	29,002 -510	-2%	-$34.3K	0.05%	281
2017 Q1	$1.92M	Sell	29,512 -7,106	-19%	-$447K	0.05%	304
2016 Q4	$2.29M	Buy	+36,618	New	+$2.24M	0.06%	253

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Glen Harbor Capital Management's ABBV Position: Q3 2019 in Review

Glen Harbor Capital Management increased its AbbVie (ABBV) stake by 58% in Q3 2019, buying an estimated $4.33M and bringing the position to 171,972 shares worth $13M. The position accounts for 0.27% of the portfolio, ranked #76.

Glen Harbor Capital Management first reported a position in ABBV in Q4 2016 and has held it in 12 quarters since. The position peaked at $26.6M in Q3 2018. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

Glen Harbor Capital Management held 171,972 shares of AbbVie worth $13M as of Q3 2019.
Glen Harbor Capital Management bought 63,172 AbbVie shares in Q3 2019, an estimated $4.33M.
AbbVie made up 0.27% of Glen Harbor Capital Management's portfolio in Q3 2019, its #76 holding.
Glen Harbor Capital Management first reported a position in AbbVie in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's AbbVie position peaked at $26.6M in Q3 2018.
2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.